Trimebutine
- Generic Name
- Trimebutine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C22H29NO5
- CAS Number
- 39133-31-8
- Unique Ingredient Identifier
- QZ1OJ92E5R
- Background
Trimebutine is a spasmolytic agent that regulates intestinal and colonic motility and relieves abdominal pain with antimuscarinic and weak mu opioid agonist effects. It is marketed for the treatment of irritable bowel syndrome (IBS) and lower gastrointestinal tract motility disorders, with IBS being one of the most common multifactorial GI disorders . It is ...
- Indication
Indicated for symptomatic treatment of irritable bowel syndrome (IBS) and treatment of postoperative paralytic ileus following abdominal surgery.
- Associated Conditions
- Irritable Bowel Syndrome (IBS), Gastrointestinal spasms, Postoperative paralytic ileus
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath